InvestorsHub Logo
Followers 14
Posts 3822
Boards Moderated 1
Alias Born 07/07/2002

Re: Traderbx post# 20123

Friday, 05/12/2017 3:24:00 PM

Friday, May 12, 2017 3:24:00 PM

Post# of 108192
grep from the website.

"AstraZeneca / MedImmune


Advaxis entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, for a Phase 1/2 study to evaluate the safety and efficacy of MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, durvalumab (MEDI4736), in combination with Advaxis’ axalimogene filolisbac as a treatment for patients with advanced, recurrent or refractory cervical cancer and HPV-associated head and neck cancer."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News